Medicus Pharma Ltd.
Bob Ciaruffoli is a seasoned leader in the biotech and technology sectors, currently serving as the Lead Director on the Board of Directors for Medicus Pharma Ltd., a company dedicated to advancing innovative therapeutic assets. As a Co-Founder and Board Member of Broad Street Angels, Ciaruffoli drives investment in early-stage businesses within the Mid-Atlantic region to foster economic growth and innovation. Previous board roles include key positions at Yellowdig, eureQa, and Prosperoware, contributing to advancements in EdTech and digital business solutions. Ciaruffoli's extensive experience in financial services is underscored by a successful tenure as Chairman and CEO of Baker Tilly, where significant growth and transformation were achieved. Ciaruffoli holds a Bachelor of Science in Accounting from King's College.
This person is not in any teams
This person is not in any offices
Medicus Pharma Ltd.
Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.